{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:41:08Z","timestamp":1792528868532,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jchromb.2026.125049","type":"journal-article","created":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T11:22:15Z","timestamp":1775388135000},"page":"125049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development and validation of an LC-MS\/MS assay for serum 5\u03b1-androstane-3\u03b1, 17\u03b2-diol 17-glucuronide with enhanced interference resolution"],"prefix":"10.1016","volume":"1277","author":[{"given":"Andr\u00e9 Filipe","family":"Rodrigues-Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Tedesco","family":"Faccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Arantes Rosa","family":"Maciel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina Helena Morais","family":"Cardozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdemir Melechco","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2026.125049_bb0005","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jchromb.2012.06.031","article-title":"Validation of a sequential extraction and liquid chromatography\u2013tandem mass spectrometric method for determination of dihydrotestosterone, androstanediol and androstanediol\u2013glucuronide in prostate tissues","volume":"902","author":"Adomat","year":"2012","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.jchromb.2026.125049_bb0010","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/jocd.12232","article-title":"Acne in adult women and the markers of peripheral 3 alpha-diol G activity","volume":"15","author":"Cunha","year":"2016","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.jchromb.2026.125049_bb0015","doi-asserted-by":"crossref","DOI":"10.1080\/19381980.2017.1361571","article-title":"ADT-G as a promising biomarker for peripheral hyperandrogenism in adult female acne","volume":"9","author":"Rocha","year":"2017","journal-title":"Dermatoendocrinol"},{"key":"10.1016\/j.jchromb.2026.125049_bb0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1210\/jcem-69-1-105","article-title":"Serum 3\u03b1-Androstanediol Glucuronide Measurements in Sexually Mature Women with Congenital Adrenal Hyperplasia during Therapy*","volume":"69","author":"Reiner","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jchromb.2026.125049_bb0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jtos.2025.06.002","article-title":"A pilot randomized controlled trial of topical androgen treatment in dry eye","volume":"38","author":"Jiang","year":"2025","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.jchromb.2026.125049_bb0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ophtha.2016.12.011","article-title":"A Metabolome-Wide Study of Dry Eye Disease Reveals Serum Androgens as Biomarkers","volume":"124","author":"Vehof","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jchromb.2026.125049_bb0035","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/chromsci\/bmv190","article-title":"Bioanalytical LC\u2013MS Method for the Quantification of Plasma Androgens and Androgen Glucuronides in Breast Cancer","volume":"54","author":"Kalogera","year":"2016","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jchromb.2026.125049_bb0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jchromb.2013.09.022","article-title":"Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: Could it raise new perspectives in the diagnostic field of hormone-dependent malignancies?","volume":"940","author":"Kalogera","year":"2013","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.jchromb.2026.125049_bb0045","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1359\/jbmr.061018","article-title":"Serum Levels of Specific Glucuronidated Androgen Metabolites Predict BMD and Prostate Volume in Elderly Men","volume":"22","author":"Vandenput","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jchromb.2026.125049_bb0050","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1530\/eje.0.1380421","article-title":"Serum levels of 3alpha-androstanediol glucuronide in hirsute and non hirsute women","author":"Falsetti","year":"1998","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jchromb.2026.125049_bb0055","doi-asserted-by":"crossref","unstructured":"M.A. KIRSCHNER, E. SAMOJLIK, E. SZMAL, Clinical Usefulness of Plasma Androstanediol Glucuronide Measurements in Women with Idiopathic Hirsutism*, J. Clin. Endocrinol. Metab. 65 (1987) 597\u2013601. Doi: https:\/\/doi.org\/10.1210\/jcem-65-4-597.","DOI":"10.1210\/jcem-65-4-597"},{"key":"10.1016\/j.jchromb.2026.125049_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2006.02.004","article-title":"Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women","volume":"99","author":"Labrie","year":"2006","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jchromb.2026.125049_bb0065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0039-128X(01)00152-0","article-title":"A highly specific heterologous enzyme immunoassay for 5\u03b1-androstane-3\u03b1, 17\u03b2-diol 17-glucuronide (androstanediol-17G) and developmental patterns of urinary androstanediol-17G excretions","volume":"67","author":"Onishi","year":"2002","journal-title":"Steroids"},{"key":"10.1016\/j.jchromb.2026.125049_bb0070","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1111\/j.1743-6109.2010.01915.x","article-title":"The Relationship between Androgens, Regulators of Collagen Metabolism, and Peyronie's Disease: A Case Control Study","volume":"7","author":"Karavitakis","year":"2010","journal-title":"J. Sex Med."},{"key":"10.1016\/j.jchromb.2026.125049_bb0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jchromb.2013.06.031","article-title":"Multiplexed analysis of steroid hormones in human serum using novel microflow tile technology and LC\u2013MS\/MS","volume":"934","author":"Broccardo","year":"2013","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2026.125049_bb0080","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1373\/clinchem.2013.213363","article-title":"Performance of Direct Estradiol Immunoassays with Human Male Serum Samples","volume":"60","author":"Handelsman","year":"2014","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jchromb.2026.125049_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6890-14-33","article-title":"Cross-reactivity of steroid hormone immunoassays: clinical significance and two-dimensional molecular similarity prediction","volume":"14","author":"Krasowski","year":"2014","journal-title":"BMC Clin. Pathol."},{"key":"10.1016\/j.jchromb.2026.125049_bb0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jchromb.2011.11.044","article-title":"The role of liquid chromatography\u2013tandem mass spectrometry in the clinical laboratory","author":"van den Ouweland","year":"2012","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2026.125049_bb0095","series-title":"The Immunoassay Handbook","first-page":"745","article-title":"Hirsutism and Virilization in the Female","author":"Wheeler","year":"2013"},{"key":"10.1016\/j.jchromb.2026.125049_bb0100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.steroids.2018.12.008","article-title":"Establishment of reference intervals for serum concentrations of androstanediol glucuronide by a newly developed LC-MS\/MS method","volume":"143","author":"Fabregat-Cabello","year":"2019","journal-title":"Steroids"},{"key":"10.1016\/j.jchromb.2026.125049_bb0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jchromb.2011.08.027","article-title":"The coming of age of liquid chromatography coupled to tandem mass spectrometry in the endocrinology laboratory","volume":"883\u2013884","author":"Carvalho","year":"2012","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2026.125049_bb0110","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1373\/clinchem.2009.138602","article-title":"Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory","volume":"56","author":"Vogeser","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jchromb.2026.125049_bb0115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jsbmb.2015.02.009","article-title":"A rapid and sensitive UPLC\u2013MS\/MS method for the simultaneous quantification of serum androsterone glucuronide, etiocholanolone glucuronide, and androstan-3\u03b1, 17\u03b2 diol 17-glucuronide in postmenopausal women","volume":"149","author":"Ke","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jchromb.2026.125049_bb0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mas.21540","article-title":"The Skyline ecosystem: Informatics for quantitative mass spectrometry proteomics","volume":"39","author":"Pino","year":"2020","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.jchromb.2026.125049_bb0125","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1093\/clinchem\/47.11.2075","article-title":"EP Evaluator-CLIA (EE-CLIA) for Evaluating Clinical Laboratory Methods (Consultant's Version with Rapid Results Entry). Kennett Square, PA: David G. Rhoads Associates, Inc., 2000, 3 diskettes and manual (142 + 33 pp.), $695.00","volume":"47","author":"Rej","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jchromb.2026.125049_bb0130","series-title":"CLIA-Compliant Analytical Method Validation Plan and Template FOR LRN-C LABORATORIES","author":"ASSOCIATION OF PUBLIC HEALTH LABORATORIES (APHL)","year":"2013"},{"key":"10.1016\/j.jchromb.2026.125049_bb0135","series-title":"Evaluation of precision of quantitative measurement procedures; Approved guideline\u2014Third edition","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2014"},{"key":"10.1016\/j.jchromb.2026.125049_bb0140","series-title":"Evaluation of the Linearity of Quantitative Measurement Procedures: A Statistical Approach; Approved Guideline","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2003"},{"key":"10.1016\/j.jchromb.2026.125049_bb0145","series-title":"EP17-A\u2014Protocols for Determination of Limits of Detection and Limits of Quantitation; Approved Guideline","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2004"},{"key":"10.1016\/j.jchromb.2026.125049_bb0150","series-title":"M10 BIOANALYTICAL METHOD VALIDATION AND STUDY SAMPLE ANALYSIS: Guidance for Industry","author":"U.S. Department of Health and Human Services Food and Drug Administration (FDA)","year":"2022"},{"key":"10.1016\/j.jchromb.2026.125049_bb0155","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10337-013-2421-y","article-title":"Novel data on the effect of tetrahydrofuran as an organic co-modifier in RP-HPLC","volume":"76","author":"Horv\u00e1th","year":"2013","journal-title":"Chromatographia"},{"key":"10.1016\/j.jchromb.2026.125049_bb0160","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.chroma.2010.09.046","article-title":"Chromatographic selectivity triangles","volume":"1218","author":"Johnson","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125049_bb0165","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1002\/rcm.4121","volume":"23","author":"Xia","year":"2009","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2026.125049_bb0170","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1194\/jlr.M079012","article-title":"Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950\u2013metabolites in frozen human plasma","volume":"58","author":"Bowden","year":"2017","journal-title":"J. Lipid Res."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226001388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226001388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:34:39Z","timestamp":1792528479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023226001388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":34,"alternative-id":["S1570023226001388"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125049","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of an LC-MS\/MS assay for serum 5\u03b1-androstane-3\u03b1, 17\u03b2-diol 17-glucuronide with enhanced interference resolution","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"125049"}}